
Nanobiotix S.A. / Fundamental strength relative to industry (Mohanram G-Value) /
The G-Value, developed by Mohanram in 2005, is a measure of a fundamental strength for growth companies. According to Mohanram, a low G-Value suggests a higher probability that a stock may be overvalued relative to its growth potential due to hype or overexcitement. The approach is described in detail in Mohanram's 2005 Paper Separating Winners from Losers among LowBook-to-Market Stocks using Financial Statement Analysis.
You are viewing the G-Value as of . Click to view the current G-Value instead.
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
- Return on assets (ROA) greater than industry median
- close -251.7% ≤ -42.9%
- Operating cash flow over total assets greater than industry median
- close -176.2% ≤ -32.8%
- Operating cash flow greater than net income
- check -$71.18M > -$101.72M
- Variance in ROA over the last 5 years less than industry median
- close 47.7% ≥ 13.7%
- Variance in year-over-year sales growth over the last 5 years less than industry median
- close 12,990.6% ≥ 376.8%
- R&D expenses over total assets greater than industry median
- check 156.0% > 51.8%
- Capex over total assets greater than industry median
- check 1.5% > 1.3%
G-Value history
The G-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the G-Value at a specific time in the past.
-
3
-
5
-
2
-
4
-
3
-
2
-
3
-
2
-
3
-
3
-
3
-
3
-
3
-
3
-
2
-
2
-
2
-
2
-
2
-
3
-
2
-
2
-
3